Febuxostat Tablet
Product Images NDC 70771-1553

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Febuxostat (NDC 70771-1553). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

40 mg Label (79ab6504 2138 4e88 9944 97823cfb21d3 01)

Label for Febuxostat Tablets 40 mg in oral tablet form by Zydus Lifesciences Limited. The label includes the NDC code 70771-1552-3 and states the package contains 30 tablets. Storage instructions specify 20° to 25°C and protection from light. It advises dispensing with a Medication Guide and includes warnings about keeping the product out of children's reach.*

FDA Label Image

80 mg Label (79ab6504 2138 4e88 9944 97823cfb21d3 02)

Label for Febuxostat Tablets 80 mg oral tablets, containing 30 tablets per package. The label includes dispensing instructions, storage conditions, a warning to keep out of reach of children, and manufacturer information (Cadila Healthcare Ltd, Ahmedabad, India). It is labeled for prescription use only and produced by Zydus Lifesciences Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.